- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Plenty of people are surprised that PhD student at Geneva School of Diplomacy and Scholar in the Law of Health at University of Lausanne's Institute for Work and Health ( IURST )became an Expert in the laws of nanotechnology to health law for the Council of Europe , the Commission EU- USA nanoehs.org , and may be the principal investigator for a new post-doctoral grant that will study the impact of nanotechnology on the quality of life for seniors who continue to work after their retirement age. Her thesis was awarded the rank of SUMA CUM LAUDE.
"I am often asked why I came back to school for my Ph.D. in international relations, since I 'm already a lawyer in the supreme court of the united states, with master of science in public health from Johns Hopkins University and I said I do not know enough ! " smiled Ilise L Feitshans JD and ScM candidate and doctorate in " Forecasting Nano Law: Protecting Public Health Risk Management Under International Law .
Ilise will present a live webinar sent from University of Lausanne to Georgetown University in Washington DC February 20, 2014 at noon there ( 8h Lausanne and Geneva) -
During her doctoral studies she gave over 40 seminars and webinars; for lawyers , doctors , engineers, and recently the general public about the course she has developed herself, a transdisciplinary intersection between the law , science, human rights and public health. Political and economic concerns, in her opinion regarding the implementation of nanotechnology policy, are the areas where in her opinion, the true test of democracy lies .
"I 'm fascinated by the question: How will the benefits of nanotechnology can be realized, while minimizing the risks?" Ilise said.
Based on the approved thesis proposal that was published in the magazine UN SPECIAL March 2011 (at the United Nations of Geneva Switzerland ) and the comments that Ilise has provided on behalf of the Work health and Survival Project , she wrote for public comment World Health Organization (WHO) on occupational exposure to engineered nanoparticles (March 2012), the thesis has already contributed to efforts for creating coherent policies and harmonization. She served as expert on the right of nanotechnology report for the Council of Europe " Benefits of Nanotechnology and balancing risks to public health and the environment" (Accepted by the Parliamentary Assembly in 2013 ). The report as discussed by the Director of Health and Sustainable Development for the Council of Europe was the basis of a public seminar in Geneva 2013.
"The revolution of nanotechnology to the global economy can revolutionize public health ," said Ilise at the conference "Law and Science of Nanotechnology:Perfect Together?" In the Museum of the History of Science in Geneva where her audience was deeply engaged.
" Consumer products apply nanotechnologies daily as coatings on car paint and protecting textiles from rodents and pest, as anti bacterial packaging in food, and in cosmetics. Not surprising, nanotechnologies are expected to be $3 trillion by 2015.By then there will be a massive bioaccumulation of the products in daily life.
Nanotechnology has been announced by scientists as a revolution for the industry.
Trade and nanomedicine products therefore raise the policy question how to protect public health. the question of how to regulate the advance of cumulative doses that may present undue risks to the public and the global burden absorbed by the public health systems , while still supporting major economic development that incubate nanotechnology industries requires planning ahead " Ilise explained.
Creating a sustainable culture of innovation for the miraculous nanotechnology products requires a legal system that does both: the foundation of sound economic growth and favorable trade policies, but --- in parallel strategy success for innovation also requires a balance between the potential risks posed by products on the environment, stakeholders and the public health. European harmonization will face its biggest challenge to date , therefore , in the design and support programs that will fund nanotechnology and nanomedicine in this regard.
Scientists and governments agree that there are unknown risks and began drafting legislation . Examples include the Swiss Federation (precaution Matrix 2008) Royal Commission on Environmental Pollution ( UK, 2008), the Committee of the German government science, public testimony sought by U.S. National Institute for Occupational Safety and Health (NIOSH , February 2011) , a working group of the OECD ( since 2007) working group of the WHO ( in training ), ISO , WTO, several industry groups, and various non -governmental organizations. No matter how much one of these laws have been designed , it is impossible to trade if all these laws apply at the same time . The resulting trade- off may inadvertently stifle industries expect policymakers will prosper !
Social transformations created by nanotechnology will also easily provide the ability to modify and correct system problems long in access , awareness and the provision of services related to public health work, because nanotechnology will change the archaic systems anyway. The time is now, however, to carefully design a regulatory framework that will depend on the evolution of the concepts of risk as they emerge on the basis of new data and applications of nanotechnology in the workplace , industrial processes , military uses, energy conservation and consumer goods that can not be imagined in the drafting of laws. There are many systems under development , but few or none harmonization efforts , which will be necessary next step if these regulations will promote , rather than serving as a barrier to medical program.
"Everyone wants to continue working when they are old , even the Queen of England ! Nanomedicine will make things that we thought was science fiction becomes real .
What will society for people who are old and able to work and want to work?" continued Ilise.
For more information, please click here
Dr ilise L Feitshans JD and ScM. And DIR
41 79 836 3965
Copyright © Dr ilise L Feitshans JDIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Healthcare Nanotechnology (Nanomedicine) Market Size To 2020 June 5th, 2015
NNI Publishes Workshop Report and Launches Web Portal on Nanosensors: Both outputs support the Nanotechnology Signature Initiative ‘Nanotechnology for Sensors and Sensors for Nanotechnology: Improving and Protecting Health, Safety, and the Environment’ June 24th, 2015
Leti Announces Launch of First European Nanomedicine Characterisation Laboratory: Project Combines Expertise of 9 Partners in 8 Countries to Foster Nanomedicine Innovation and Facilitate Regulatory Approval July 1st, 2015